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Background. Respiratory syncytial virus (RSV) is an important cause of infant morbidity and mortality and a potential target
for maternal immunization strategies. However, data on the role of RSV in young infant deaths in developing countries are limited.
Methods. We conducted a community-based mortality surveillance from August 2018–March 2020 for infants ≤6 months in
Karachi, Pakistan. We tested (reverse transcription–polymerase chain reaction) nasopharyngeal swabs from deceased infants for presence of RSV. We performed verbal autopsies and calculated odds of RSV-associated mortality with 95% CIs and used multivariable
logistic regression to evaluate associations.
Results. We collected 490 nasopharyngeal specimens from 1280 eligible infant deaths. There were 377/490 (76.9%) live births
and 14/377 (3.7%; 95% CI: 1.8–5.6) were RSV positive. Most deaths occurred in neonates (254/377; 67.4%), males (226/377; 59.9%),
and respiratory illnesses (206/377; 54.6%). Postneonatal age (10/14, 71.4%; OR: 5.5; 95% CI: 1.7–18.0), respiratory symptoms (12/14,
85.7%; OR: 5.2; 1.2–23.7), and high RSV season (9/14, 64.3%; OR: 4.4; 1.4–13.3) were associated with RSV mortality. In multivariable
logistic regression analysis, respiratory symptoms (OR: 6.6; 95% CI: 1.3–32.5), RSV seasonality (6.1; 1.8–20.4), and age (9.2;
2.6–33.1) were significant predictors of RSV-associated mortality.
Conclusions. RSV has a significant mortality burden in early infancy in Karachi, Pakistan. Age, RSV seasonality, and respiratory symptoms were significant predictors of RSV-associated mortality. Our findings have implications for clinical management of
young infants with cold-like symptoms, policy development, and research regarding maternal immunization against RSV during
pregnancy, in resource-constrained, low-income, and vaccine-hesitant populations.
Keywords. respiratory syncytial virus; maternal vaccine; community-based mortality surveillance; verbal autopsy.
Respiratory syncytial virus (RSV) is a respiratory pathogen with an
initial global burden of disease estimates indicating a moderate to
high burden in developing countries, specifically among young infants [1–4]. This virus is a potential target for maternal immunization strategies to prevent disease and early death in young infants.
However, due to a lack of definitive evidence, the role of RSV in neonatal and young infant mortality in low- and middle-income countries is not known [5]. Moreover, most current studies estimate RSV
disease burden only in terms of facility-based (hospital or clinic)
deaths and hospital-acquired infections. Thus, there is a knowledge gap regarding the proportion of community-based deaths
due to RSV. Furthermore, there are many challenges to generating
high-quality evidence for the role of RSV in infant mortality, such
as lack of resources for hospital and community surveillance and
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diagnostics and difficulty in obtaining specimens in populations
where burial occurs within hours after death [6]. Therefore, there
are limited direct data on the incidence and severity of RSV and
the associated early deaths in specific populations [1, 3], resulting in
insufficient evidence to inform policy considerations for maternal
and childhood immunization schedules [7].
Pakistan has one of the highest infant mortality rates globally
due to multiple causes, but little is known about the RSV burden
in infant mortality [8]. The primary objective of this study was to
assess and analyze the burden and determinants of RSV mortality
in infants in the urban areas of Karachi, Pakistan. We conducted a
community-based mortality surveillance study to obtain more accurate estimates of RSV-associated deaths in young infants in these
areas. This is a seminal community-based RSV mortality study in
Pakistan, made possible due to close liaison with the communities
to collect nasopharyngeal swab samples from deceased infants.
METHODS

This was an observational community-based mortality surveillance study conducted in 4 peri-urban low-income settlements
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Respiratory Syncytial Virus–Associated Mortality Among
Young Infants in Karachi, Pakistan: A Prospective
Postmortem Surveillance Study

and before burial is religiously acceptable in the context of the
Islamic, Christian, and Hindu faiths. Infant death alerts were
conveyed to the team from key community stakeholders, such
as religious leaders, traditional birthing attendants, and graveyard personnel.
Upon receiving a death alert from a key community partner
or community member, the RSV study team mobilized from the
primary health center at the field site to the identified household of the deceased infant. Due to the religious beliefs of predominantly Muslim communities, burial of the deceased occurs
as soon as possible. Hence, there was a short time window for
enrollment before the ritual bathing, shrouding, and burial of
the infant. A 24 × 7 surveillance system was established to mobilize the study team to approach a household within 25 minutes of receiving a death alert.
As Muslim burials generally occur within 24 hours of death and
the staff received most alerts within 1 hour of the infant’s death, we
had no concerns about the viability of specimens for collection.
The nurse performing the nasopharyngeal specimen collection
donned a surgical mask and clean gloves to minimize exposure.
Laboratory staff were trained in specimen testing methods for

Figure 1. Cohort diagram on infant mortality and data collected and tested for RSV from August 2018 to March 2020 in Karachi, Pakistan. Inclusion criteria were deceased
infants aged less than 6 months in catchment areas. Patients were excluded if they were older than 6 months or from out of catchment areas. Abbreviation: RSV, respiratory
syncytial virus.
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(Rehri Goth, Ibrahim Hyderi, Bhains Colony, and Ali Akbar
Shah) in Karachi, Pakistan. The overall population of the catchment area is approximately 249 128, with a cohort of approximately 7525 new births per year [9].
Data were collected from August 2018 to March 2020. The
primary outcome measure was prevalence of laboratoryconfirmed (reverse transcription–polymerase chain reaction [RT-PCR]) RSV infection in nasopharyngeal specimens
from recently deceased infants younger than 6 months. The
study enrollment inclusion criteria comprised stillborn or recently deceased infants under 6 months of age in the catchment areas. Parents or other caregivers gave informed verbal
consent for a nasopharyngeal swab collection from their
deceased infant at the household preferably before ritual
cleansing and shrouding, and before burial.
Prior to the onset of the surveillance phase, we conducted
a formative phase where we explored the acceptance of study
procedures within the communities and assessed the benefits
to families of deceased infants for participating in the study. We
obtained approval and religious rulings from religious scholars
that collecting specimens via nasopharyngeal swabs after death

Storage and Archiving

Nasopharyngeal specimens were stored at 70°C or lower prior
to nucleic acid extraction until sufficient samples were available
for batch testing. Nucleic acid was extracted from frozen aliquots using QIAamp Viral RNA Mini Kit (Qiagen).
Laboratory Tests for Primary Confirmation of Respiratory Syncytial Virus

The extracted nucleic acids (from a Roche MagNApure compact
automated system) were used for 1-step real-time PCR for RSV
detection, using a Qiagen 1-step RT-PCR kit. Real-time RT-PCR
assays were performed with primers and probes for RSV, using
the CDC protocol [11]. All assays were run with positive controls
(RSV-RNA), negative controls (nuclease-free water), and internal positive controls (RNAseP) for quality-control purposes.
Home Visits and Cause of Death Consultation

A psychologist trained the field team in grief support and communication skills to conduct home visits for bereaved parents
at the time of and up to 2 months after the infant’s death. The
World Health Organization (WHO) verbal and social autopsy

Figure 2. Number of deceased infants enrolled and RSV-positive cases by month and year. This shows trends in enrollment between August 2018 and March 2020 with
number of RSV-positive cases per month. August 2018 to December 2018 was the pilot surveillance phase. The monsoon season (lots of rain) in Karachi, Pakistan, is between
July and September. This coincides with their high-RSV season, which is from August to October. Abbreviation: RSV, respiratory syncytial virus.
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RSV. After obtaining verbal consent from the deceased infant’s
parents/caregivers and completing the Case Record Form (see
Supplementary Material), trained personnel collected a nasopharyngeal swab from each nostril using Pernasal Dacron swabs. The
swab was inserted nasally and advanced along the floor of the
nose until it reached the nasopharynx and held against the posterior nasopharynx for a few seconds, based on Centers for Disease
Control and Prevention (CDC) guidelines [10], before removal.
The first swab was immediately placed in a Universal Transport
Media (UTM) tube, then placed on cold packs or in wet ice (~2–
4°C) to prevent loss in viral titer. The second swab was immediately placed in semi-solid Regan-Lowe transport medium, then
placed on cold packs or in wet ice (~2–4°C) to prevent loss in bacterial titer (for a separate pertussis study not included in this manuscript). The samples were stored in UTM tubes and transported
to the laboratory. Transport to the Aga Khan University Infectious
Disease Research Laboratory occurred 3 times a day: morning, afternoon, and evening. During transport, the sample was held at
2–4°C. It was stored at −70°C or lower upon receipt.

tool was administered during grief-support home visits within
a week of enrollment. A cause of death report containing verbal
and social autopsy findings and laboratory-confirmed PCR results for RSV was shared with enrolled parents alongside continuous community engagement activities.

Table 1. Clinical and Demographic Characteristics of the Deceased LiveBirth Infants: August 2018–March 2020, Karachi, Pakistan
RSV Status
Positive, n (%)

Total, n (%)

363 (96.3)

14 (3.7)

377 (100.0)

0–3 months

320 (88.2)

12 (85.7)

332 (88.1)

≥3 months

43 (11.8)

2 (14.3)

45 (11.9)

Neonatal:
0–28 days

250 (68.9)

4 (28.6)

254 (67.4)

Non-neonatal:
≥29 days

113 (31.1)

10 (71.4)

123 (32.6)

Female

146 (40.2)

5 (35.7)

151 (40.1)

Male

217 (59.8)

9 (64.3)

226 (59.9)

Ali Akbar Shah
Goth

102 (28.1)

10 (71.4)

112 (29.7)

Bhains Colony

107 (29.5)

2 (14.3)

109 (28.9)

Ibrahim Hyderi

73 (20.1)

2 (14.3)

75 (19.9)

Rehri Goth

81 (22.3)

0 (0.0)

81 (21.5)

Total, n (%)

Verbal Autopsy—Identifying Cases and Controls

To determine the cause of death, the following was considered:
(1) nasopharyngeal swab test results, (2) medical records of
symptoms (when available), and (3) verbal and social autopsy.
Symptoms obtained through verbal autopsy as well as medical
records, when available, were considered to determine the likely
cause of death. Cases were deceased infants who had respiratory
symptoms as per acute lower respiratory infection (ALRI) criteria (cough, wheezing, rhonchus, crackles, etc). Controls were
deceased infants who did not have any of the defined respiratory symptoms.
Statistical Analysis

To determine RSV burden, we calculated crude RSV mortality
proportions and the odds of having laboratory-confirmed
RSV among cases and controls of deceased infants captured
through our surveillance system. Our symptom-based case
definitions for respiratory disease cases was a deceased livebirth infant who had at least 1 of these respiratory symptoms that occurred within 2 weeks immediately preceding
death, with no asymptomatic period between symptom onset
and death: (1) cough, (2) difficulty breathing, (3) chest wall
indrawing, (4) wheezing, (5) rhonchus, or (6) crackles when
breathing and any one of the very severe symptoms (headnodding, lethargy, convulsions, cyanosis, difficulty breastfeeding, or vomiting) [9, 12]. Very severe ALRI includes
presence of respiratory symptoms plus unconsciousness,
poor feeding, lethargy, and convulsions. Controls were defined as deceased live-birth infants who did not meet the
symptom-based case definition above.
To determine predictors of RSV mortality, we compared the
distribution of covariates such as hospital deaths versus community deaths and gender, age, or seasonality among infants with
and without laboratory-confirmed RSV (controls) using chisquare tests and odds ratios (ORs). Since we did not have access
to the medical records of most of the deceased infants to determine the details of length of hospital stay for the entire sample,
we defined hospital deaths as deaths that occurred inside a tertiary care hospital, regardless of duration of time in the hospital.
Community deaths were defined as infants who died either
on the way to the hospital, in the traditional birth attendant’s
home, at the clinic, at home, or in a community-based health
center. Age was categorized as 0–3 months and 4–6 months,
as well as neonatal (0–28 days old) and post-neonatal (29 days
and older) for analysis. Stillborn infants were not included in
the analyses as we would not expect to see any RSV in them
S206 • cid 2021:73 (Suppl 3) • Kazi et al

Age at death

Age at death

Sex

Study site

Place of death
Community

185 (51.0)

4 (28.6)

189 (50.1)

Hospital

178 (49.0)

10 (71.4)

188 (49.9)

Case

194 (53.4)

12 (85.7)

206 (54.6)

Control

169 (46.6)

2 (14.3)

171 (45.4)

Low (November
to July)

257 (70.8)

5 (35.7)

262 (69.5)

High (August to
October)

106 (29.2)

9 (64.3)

115 (30.5)

ALRI

84 (23.1)

4 (28.6)

88 (23.3)

Severe ALRI

19 (5.2)

3 (21.4)

22 (5.8)

Very severe
ALRI

91 (25.1)

5 (35.7)

96 (25.5)

169 (46.6)

2 (14.3)

171 (45.4)

Symptom-based
case definitions

Season of illness
and death

ALRI
classificationa

No respiratory
symptoms

Abbreviations: ALRI, acute lower respiratory infection; RSV, respiratory syncytial virus.
a
ALRI, cough or difficulty breathing with increased respiratory rate for age; Severe ALRI,
ALRI with wheeze and chest wall indrawing; Very severe ALRI, ALRI with at least 1 danger
sign (eg, cyanosis, difficulty in breastfeeding or drinking, vomiting, convulsions, lethargy,
unconsciousness, poor feeding, unconsciousness).

(never exposed to RSV). RSV seasonality in Pakistan was defined based on a prospective surveillance study conducted at
the Aga Khan University Hospital in Karachi, Pakistan [13].
RSV is identified year-round in Pakistan but is most prevalent
during the rainy season, which is from August to October with
a peak in September. For analyses, we classified RSV seasonality
as “high” (August to October) and “low” (November to July).
Multivariable logistic regression was used to assess the association of these covariates on RSV positivity among deceased infants. This will provide key information regarding the extent to
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Negative, n (%)

Variable

Table 2.

Comparing Distribution of Covariates Among Deceased Infants with Laboratory-Confirmed Respiratory Syncytial Virus Status (Chi-Square)

Variable

OR

95% Confidence Limits

377

5.2

1.2–23.7

.02

P

Place of death (hospital vs community)

377

2.6

.8–8.4

.10

Gender (male vs female)

377

1.2

.4–3.7

.74

Age (0–3 months vs ≥3 months)

377

1.2

.3–5.7

.78

Age (non-neonatal vs neonatal)

377

5.5

1.7–18.01

.0016

Seasonality (high vs low)

377

4.4

1.4–13.3

.0051

Number of observations shows the total number of enrolled live-birth infants tested for RSV = 377. The outcome is RSV-positive status. Abbreviations: OR, odds ratio; RSV, respiratory
syncytial virus.

which severe disease (eg, requiring care in a hospital prior to
death) is associated with RSV positivity, while adjusting for the
presence or absence of other covariates.
Approval from the Ethical Review Committee/Institutional
Review Boards (IRBs) of Yale University and Aga Khan
University was obtained. Study protocol, all data-collection instruments, and consent forms (into English as well as in local
languages) were also approved by both institutions’ IRBs.
RESULTS

Of 1280 eligible infant deaths that occurred between August
2018 and March 2020 in the catchment areas, 490 nasopharyngeal specimens were obtained; 113 of 490 (23.1%) were
stillborn and 14 of 377 (3.7%; 95% confidence interval [CI]:
1.8–5.6%) live-birth infant specimens tested positive for RSV.
Figure 1 shows the cohort diagram. Most of the deceased livebirth infants were males (226/377; 59.9%) and aged 0–3 months
old (332/377; 88.1%) or neonates (254/377; 67.4%). The mean
age of the population studied was 30.3 months (95% CI: 28.7–
31.9 months) and the median age was 6.0 months. Figure 2 indicates trends in enrollment between August 2018 and March
2020 with RSV seasonality.
Attribution of Respiratory Deaths

The proportion of deceased infants with laboratory-confirmed
RSV was 14 of 377 (3.7%) (Table 1). There was a similar

proportion of deaths in the community or hospital; however,
most of the RSV cases (10/14; 71.4%) died in a hospital. It is
important to note that, for some of the infants whose medical
records were available, while they did not spend up to 24 to 48
hours in the hospital where they died, they presented at several
hospitals for the fatal illness. Two of the RSV-positive cases who
died in the hospital within 24 hours of hospitalization were admitted to the intensive care unit prior to death.
To compare the distribution of covariates among deceased
infants with laboratory-confirmed RSV status vs no RSV, we
calculated odds ratio (see Table 2). While the majority (67.4%;
254/377) of the deceased live-birth infants died during the neonatal period, most of the RSV-positive cases (71.4%; 10/14)
were among infants who died after the neonatal period (OR:
5.5; 95% CI: 1.7–18.01). Deceased infants who had respiratory
symptoms during fatal illness were more likely to test positive
for RSV versus those who had no respiratory symptoms during
fatal illness (12/14, 85.7%; OR: 5.2; 95% CI: 1.2–23.7). Infants
who died during the high-RSV season were more likely to test
positive for RSV compared with those who died during the lowRSV season (64.3%, 9/14; OR: 4.4; 95% CI: 1.4–13.3).
In multivariable logistic regression, we found that age
(>28 days) (OR: 9.2; 95% CI: 2.6–33.1), having respiratory
symptoms (OR: 6.6; 95% CI: 1.3–32.5), and RSV seasonality
(OR: 6.1; 95% CI: 1.8–20.4) were significant predictors of testing
RSV positive (Table 3).

Table 3. Multivariable Logistic Regression Model of Prediction of Respiratory Syncytial Virus Positivity in Infants Who Died from August 2018 to March
2020 in Karachi, Pakistan
Variables

Estimate

Standard Error

Wald Chi-Square

Pr > ChiSq

Intercept

–9.9

2.0

24.6

<.0001

OR

95% CI
2.6–33.1

Age (non-neonate vs neonate)

2.2

0.7

11.6

.0007

9.2

Sex (male vs female)

0.3

0.6

0.2

.6255

1.4

.4–4.5

Symptom-based case definitions for
respiratory disease (case vs control)

1.9

0.8

5.4

.0203

6.6

1.3–32.5

Place of death (hospital vs community)

1.0

0.6

2.5

.1167

2.7

.8–9.5

Season (high vs low)

1.8

0.6

8.6

.0034

6.1

1.8–20.4

The number of enrolled live birth infants tested for RSV = 377, chi-square = 28.9, df = 5, P = .0001. Probability model shows RSV status = positive; convergence criterion (GCONV = 1E-8)
satisfied. References: Age: 0–3 months; Sex: female; Cases: acute lower respiratory infection; Place of death: community; and Seasonality: low. Abbreviations: CI, confidence interval; OR,
odds ratio; RSV, respiratory syncytial virus.
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Number of Observations

Symptom-based case definitions for
respiratory disease (case vs control)

DISCUSSION
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